Human immunodeficiency virus prevention strategies in China
- PMID: 31929359
- PMCID: PMC7004624
- DOI: 10.1097/CM9.0000000000000647
Human immunodeficiency virus prevention strategies in China
Abstract
This paper reviews the current epidemics of human immunodeficiency virus (HIV) infection in China, particularly the globally available prevention strategies developed and implemented. This review focuses on HIV prevention measures in general, such as education, testing, and counseling and in specific responses to transmission modes, such as blood safety, harm reduction for people who inject drugs, and condom promotion to reduce sexual transmission. We also assess newly developed prevention measures, such as prevention treatment, pre-exposure prophylaxis, post-exposure prophylaxis, male circumcision, and promising potential future preventions, including microbicides and vaccines. Based on this assessment, we provide recommendations for their implementation in China. We conclude that there is no magic bullet for HIV prevention, particularly sexual transmission of the disease, but only a combination of these prevention strategies can control the HIV epidemic.
Conflict of interest statement
None.
References
-
- Wu Z, Rou K, Cui H. The HIV/AIDS epidemic in China: history, current strategies and future challenges. AIDS Educ Prev 2004; 16: 3 Suppl A: 7–17. doi: 10.1521/aeap.16.3.5.7.35521. - PubMed
-
- Cui Y, Liau A, Wu ZY. An overview of the history of epidemic of and response to HIV/AIDS in China: achievements and challenges. Chin Med J 2009; 122:2251–2257. doi: 10.3760/cma.j.issn.0366-6999.2009.19.013. - PubMed
-
- Wu Z. HIV/AIDS in China-beyond the Numbers. Singapore: People's Medical Publishing House and Springer Nature; 2017.
-
- Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:1005–1070. doi: 10.1016/S0140-6736(14)60844-8. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical